AMD Options: Monoclonal Antibody Tx Effective, Safe for Neovascular AMD
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
price
Free
AMD Options: Monoclonal Antibody Tx Effective, Safe for Neovascular AMD is organized by Projects In Knowledge Inc. (PIK).
Release Date: Mar 30, 2023
Termination Date: Mar 29, 2024
Activity Goal:
The goal of this CME/CE activity is to provide comprehensive and up-to-date information on the best practices in age-related macular degeneration
Learning Objective(s):
• Summarize the clinical trial data for the treatment strategies and newly approved therapies and their potential for lessening treatment burden in patients with AMD.
• Cite early data of emerging treatment modalities.
Additional details will be posted as soon as information is available.